Colgate-Palmolive (NYSE:CL) Shares Bought by Griffin Asset Management Inc.

Griffin Asset Management Inc. boosted its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 2.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 17,421 shares of the company’s stock after buying an additional 405 shares during the quarter. Griffin Asset Management Inc.’s holdings in Colgate-Palmolive were worth $1,584,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. D Orazio & Associates Inc. grew its position in Colgate-Palmolive by 3.9% in the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after buying an additional 108 shares during the last quarter. Fiducient Advisors LLC increased its stake in shares of Colgate-Palmolive by 5.2% during the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after acquiring an additional 110 shares during the period. Sequoia Financial Advisors LLC raised its holdings in Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares in the last quarter. Great Waters Wealth Management lifted its position in Colgate-Palmolive by 1.5% in the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock valued at $796,000 after purchasing an additional 117 shares during the period. Finally, Waldron Private Wealth LLC increased its position in Colgate-Palmolive by 2.1% during the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock worth $585,000 after purchasing an additional 118 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CL. JPMorgan Chase & Co. dropped their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays cut their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Finally, Piper Sandler decreased their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $101.11.

Check Out Our Latest Stock Report on Colgate-Palmolive

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Stock Performance

NYSE CL opened at $91.19 on Tuesday. The firm has a market capitalization of $74.50 billion, a P/E ratio of 26.13, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The firm’s fifty day moving average price is $91.81 and its two-hundred day moving average price is $97.45. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.19%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.